Abstract
Corrigendum to: Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke and Low quality of some generic cardiovascular medicinal products represents a matter for growing concern.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have